Controversial bill to boost US medical research funding is passed in House of RepresentativesBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3831 (Published 14 July 2015) Cite this as: BMJ 2015;351:h3831
- Michael McCarthy
A bill that will substantially boost funding for the US National Institutes of Health (NIH), but which critics have said contains provisions that undermine the US drug approval process, was easily passed in the US House of Representatives on 10 July, in a vote of 344 to 77.
If passed by the Senate in its present form and signed into law, the bill, called the 21st Century Cures Act, would increase funding for the NIH by nearly $9bn (£5.8bn; €8.1bn) over five years.1 An additional $550m would go to the Food and Drug Administration to enable it to streamline and expedite drug and medical device approvals along the lines mandated by the bill.
Log in using your username and password
Log in through your institution
Sign up for a free trial